Historically, myelofibrosis treatment was palliative in nature, aimed at relieving specific symptoms. The discovery of the ...

These findings suggest that the presence of JAK2 mutations may complicate the clinical picture of CML, leading to misinterpretations of disease progression or treatment resistance[4]. Moreover ...

In an interview, Andrew Kuykendall, MD, discussed fedratinib’s potential as an effective option for patients with ...